Richard J. O'Reilly spends much of his time researching Immunology, Transplantation, Bone marrow, Internal medicine and Leukemia. His work deals with themes such as Immunosuppression, Severe combined immunodeficiency and Histocompatibility, which intersect with Transplantation. He interconnects Haematopoiesis, Cyclophosphamide, Absolute neutrophil count and Immunity in the investigation of issues within Bone marrow.
His Internal medicine research incorporates elements of Gastroenterology, Surgery and Oncology. His Leukemia research is multidisciplinary, incorporating perspectives in Myeloid and Marrow transplantation. His study in Human leukocyte antigen is interdisciplinary in nature, drawing from both Cytotoxic T cell and Virology.
His primary areas of investigation include Internal medicine, Immunology, Transplantation, Hematopoietic stem cell transplantation and Gastroenterology. Richard J. O'Reilly combines subjects such as Surgery and Oncology with his study of Internal medicine. His Immunology course of study focuses on Cytotoxic T cell and CD8 and Molecular biology.
Richard J. O'Reilly works mostly in the field of Transplantation, limiting it down to topics relating to CD34 and, in certain cases, Hematopoietic cell. He has included themes like Incidence, Severe combined immunodeficiency and Multiple myeloma in his Hematopoietic stem cell transplantation study. His Gastroenterology research integrates issues from Myeloid, Neutrophil Engraftment and Acute leukemia.
His main research concerns Internal medicine, Transplantation, Oncology, CD34 and Gastroenterology. The concepts of his Transplantation study are interwoven with issues in Ex vivo, Hematopoietic cell, Immunology, Cord blood and T cell. His Immunology research is multidisciplinary, incorporating elements of Cytotoxic T cell and Cell therapy.
His studies in Oncology integrate themes in fields like Cancer, Transplantation outcomes, Pathology and Rituximab. His research in Gastroenterology intersects with topics in Progression-free survival, Myeloid, Graft-versus-host disease, Bone marrow and Acute leukemia. His Hematopoietic stem cell transplantation research incorporates themes from Retrospective cohort study, Leukemia and Severe combined immunodeficiency.
The scientist’s investigation covers issues in Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Ex vivo and Oncology. His Internal medicine research includes elements of Gastroenterology, CD34 and Surgery. His biological study spans a wide range of topics, including Calcineurin, Cumulative incidence and Bone marrow.
His work deals with themes such as Myeloid and Incidence, which intersect with Transplantation. His studies deal with areas such as Severe combined immunodeficiency and Leukemia, Immunology, Immune system as well as Hematopoietic stem cell transplantation. Richard J. O'Reilly is studying T cell, which is a component of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation
Esperanza B. Papadopoulos;Marc Ladanyi;David Emanuel;Stephen Mackinnon.
The New England Journal of Medicine (1994)
Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts
David Lyden;Alison Z. Young;David Zagzag;Wei Yan.
Cytomegalovirus Pneumonia after Bone Marrow Transplantation Successfully Treated with the Combination of Ganciclovir and High-Dose Intravenous Immune Globulin
David Emanuel;Isabel Cunningham;Kethy Jules-Elysee;Joel A. Brochstein.
Annals of Internal Medicine (1988)
Effects of Recombinant Human Granulocyte Colony-Stimulating Factor on Neutropenia in Patients with Congenital Agranulocytosis
Mary Ann Bonilla;Alfred P. Gillio;Mary Ruggeiro;Nancy A. Kernan.
The New England Journal of Medicine (1989)
Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009
Sung Yun Pai;Brent R. Logan;Linda M. Griffith;Rebecca H. Buckley.
The New England Journal of Medicine (2014)
Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates.
K. Welte;M. A. Bonilla;A. P. Gillio;T. C. Boone.
Journal of Experimental Medicine (1987)
Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.
Nancy A. Kernan;Nancy H. Collins;Lisa Juliano;Teresa Cartagena.
Bone Marrow–Allograft Rejection by T Lymphocytes Recognizing a Single Amino Acid Difference in HLA-B44
Katharina Fleischhauer;Nancy A. Kernan;Richard J. O'Reilly;Bo Dupont.
The New England Journal of Medicine (1990)
Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
Ekaterina S. Doubrovina;Mikhail M. Doubrovin;Elena Vider;Richard B. Sisson.
Journal of Immunology (2003)
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
Ekaterina Doubrovina;Banu Oflaz-Sozmen;Susan E. Prockop;Nancy A. Kernan.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: